Oncology
IAPM Launches Oncology Pillar at ASCO: Closing the Gap Between Cancer Breakthroughs and Patient Access
CHICAGO, June 2026: The International Alliance for Personalised Medicine launched its Oncology Pillar at ASCO with a packed room and a clear message: oncology science is advancing at extraordinary speed, but too many patients still face barriers to the tests, trials, and treatments that could change their lives.
FDA Puts AI Inside the Evidence Machine
AlphaGenome Makes Variant Interpretation Political
AI Diagnosis Has Entered the Access Debate
Oncology Trials Still Do Not Match the Patients They Will Treat
Cancer Pharmacogenomics Exposes an Ancestry Gap in Routine Testing
Biomarker Testing Is Rising, But Eligibility Still Gets Lost
Colon Cancer MRD Testing Is Nearing the Access Threshold
Breast Cancer Blood Tests Could Bring Treatment Decisions Earlier
Lung Cancer Screening Now Has a Diagnostic Bottleneck
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.